The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study

References

• Lopez-CamposJLTanWSorianoJBGlobal burden of COPDRespirology2016211142326494423
   PubMed Web of Science ®Google Scholar
• LopezADMathersCDEzzatiMJamisonDTMurrayCJGlobal and regional burden of disease and risk factors, 2001: systematic analysis of population health dataLancet200636795241747175716731270
   PubMed Web of Science ®Google Scholar
• ManninoDMBuistASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet2007370958976577317765526
   PubMed Web of Science ®Google Scholar
• BeranDZarHJPerrinCMenezesAMBurneyPForum of International Respiratory Societies working group collaborationBurden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countriesLancet Respir Med20153215917025680912
   PubMed Web of Science ®Google Scholar
• BhattSPWellsJMDransfieldMTCardiovascular disease in COPD: a call for actionLancet Respir Med201421078378525298057
   PubMed Web of Science ®Google Scholar
• PauwelsRARabeKFBurden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet2004364943461362015313363
   PubMed Web of Science ®Google Scholar
• WedzichaJASinghRMackayAJAcute COPD exacerbationsClin Chest Med201435115716324507843
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• DecramerMLChapmanKRDahlRINVIGORATE investigatorsOnce-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group studyLancet Respir Med20131752453324461613
   PubMed Web of Science ®Google Scholar
• UzunSDjaminRSKluytmansJAAzithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trialLancet Respir Med20142536136824746000
   PubMed Web of Science ®Google Scholar
• ZhengJPWenFQBaiCXPANTHEON study groupTwice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trialLancet Respir Med20142318719424621680
   PubMed Web of Science ®Google Scholar
• GartlehnerGHansenRACarsonSSLohrKNEfficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesAnn Fam Med20064325326216735528
   PubMed Web of Science ®Google Scholar
• MateraMGCardaciVCazzolaMRoglianiPSafety of inhaled corticosteroids for treating chronic obstructive pulmonary diseaseExpert Opin Drug Saf201514453354125557156
   PubMed Web of Science ®Google Scholar
• CummingRGMitchellPLeederSRUse of inhaled corticosteroids and the risk of cataractsN Engl J Med199733718149203425
   PubMed Web of Science ®Google Scholar
• GarbeELeLorierJBoivinJFSuissaSInhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucomaJAMA199727797227279042844
   PubMed Web of Science ®Google Scholar
• HubbardRBSmithCJSmeethLHarrisonTWTattersfieldAEInhaled corticosteroids and hip fracture: a population-based case-control studyAm J Respir Crit Care Med200216612 Pt 11563153612406825
   PubMed Web of Science ®Google Scholar
• IsraelEBanerjeeTRFitzmauriceGMKotlovTVLaHiveKLeBoffMSEffects of inhaled glucocorticoids on bone density in premenopausal womenN Engl J Med20013451394194711575285
   PubMed Web of Science ®Google Scholar
• van BovenJFde Jong-van den BergLTVegterSInhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysisDrug Saf201336423123623516006
   PubMed Web of Science ®Google Scholar
• ChengSLSuKCWangHCPerngDWYangPCChronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumoniaDrug Des Devel Ther20148601607
   Web of Science ®Google Scholar
• NanniniLJPoolePMilanSJKestertonACombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20138Cd00682623990350
   PubMed Web of Science ®Google Scholar
• SuissaSCoulombeJErnstPDiscontinuation of inhaled corticosteroids in COPD and the risk reduction of PneumoniaChest201514851177118326110239
   PubMed Web of Science ®Google Scholar
• SuissaSPatenaudeVLapiFErnstPInhaled corticosteroids in COPD and the risk of serious pneumoniaThorax201368111029103624130228
   PubMed Web of Science ®Google Scholar
• JansonCLarssonKLisspersKHPneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS)BMJ2013346f330623719639
   PubMed Web of Science ®Google Scholar
• FinneyLBerryMSinganayagamAElkinSLJohnstonSLMalliaPInhaled corticosteroids and pneumonia in chronic obstructive pulmonary diseaseLancet Respir Med201421191993225240963
   PubMed Web of Science ®Google Scholar
• KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143Cd010115
   Google Scholar
• BrattsandRMiller-LarssonAThe role of intracellular esterification in budesonide once-daily dosing and airway selectivityClin Ther200325Suppl CC28C4114642802
   PubMed Web of Science ®Google Scholar
• DalbyCPolanowskiTLarssonTBorgstromLEdsbackerSHarrisonTWThe bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trialRespir Res20091010419878590
   PubMed Web of Science ®Google Scholar
• EkALarssonKSiljerudSPalmbergLFluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophagesAllergy199954769169910442524
   PubMed Web of Science ®Google Scholar
• RennardSITashkinDPMcElhattanJEfficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trialDrugs200969554956519368417
   PubMed Web of Science ®Google Scholar
• ThorssonLEdsbackerSKallenALofdahlCGPharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via TurbuhalerBr J Clin Pharmacol200152552953811736861
   PubMed Web of Science ®Google Scholar